Oruka Therapeutics, Inc. · NASDAQ:ORKA

Sandler Laura Lee sold 906 Oruka Therapeutics, Inc. shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 15, 2026

On Sep 15, 2026, Sandler Laura Lee (Chief Operating Officer) sold 906 Oruka Therapeutics, Inc. shares at US$95.71 for US$86,713, leaving 235,478 shares. Filed Sep 15, 2026 (Form 4).

Sold
906 shares
Price
US$95.71
Value
US$86,713
Holding after
235,478 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockSale906US$95.71235,478Direct

Source

View original at SEC

Related